This PhD project aims to inform substance dependence prevention and treatment by utilising population-representative epidemiological and observational data to develop and validate models of substance dependence related outcomes.
Methamphetamine use in Aboriginal communities has gained much media attention, despite limited research studies to ascertain the full extent of its use and its impact.
Retrospective study of all deaths among people undergoing naltrexone treatment for opioid dependence retrieved from the National Coronial Information System, 2000-2017.
The Quit Smoking Study is a Clinical Trial being conducted by the National Drug and Alcohol Research Centre (NDARC) at UNSW Sydney. The trial is looking at different types of nicotine replacement products to see which is the most effective at helping low-income smokers quit.
Retaining patients in buprenorphine treatment is essential in maximising treatment outcomes and minimising mortality risk. Delivery of treatment via novel depot buprenorphine products has the potential to enhance patient adherence and retention in treatment.
This PhD project will examine untreated remission from alcohol problems. This will involve understanding the way in which those with alcohol problems engage in ‘spontaneous remission’ or ‘natural recovery’ outside the treatment setting.
This project will use linked administrative data to understand risk for mortality and other adverse outcomes during and after opioid agonist treatment (OAT). It will use standard biostatistical approaches and sophisticated machine learning techniques.
This project attempts to understand the global epidemiology of infectious disease among prisoners in all countries.
Alcohol and other drug (AOD) treatment is key for improving health and reducing the social impact of AOD use. However, the treatment itself is not the only variable that impacts on whether health outcomes are improved.
